P21-ACTIVATED KINASE INHIBITOR

The present invention addresses the problem of providing an inhibitor which has an excellent inhibitory activity on a p21-activated kinase. The present invention, by which has been solved the above-mentioned problem, is a p21-activated kinase 1 inhibitor containing, as an active ingredient, one or m...

Full description

Saved in:
Bibliographic Details
Main Authors TAIRA Nozomi, NGUYEN Cao Quan Binh, TAWATA Shinkichi
Format Patent
LanguageEnglish
Published 07.12.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
STEROIDS
Online AccessGet full text

Cover

More Information
Summary:The present invention addresses the problem of providing an inhibitor which has an excellent inhibitory activity on a p21-activated kinase. The present invention, by which has been solved the above-mentioned problem, is a p21-activated kinase 1 inhibitor containing, as an active ingredient, one or more compounds selected from the group consisting of dehydrokawain compounds, derivatives of dehydrokawain compounds, mimosine, derivatives of mimosine, and cucurbitacin compounds.
Bibliography:Application Number: US201415539947